Literature DB >> 2971693

Comparison of the stability of topical isotretinoin and topical tretinoin and their efficacy in acne.

D J Elbaum1.   

Abstract

After 4 hours of exposure to incandescent light, 80% of 0.05% topical isotretinoin and 60% of 0.05% topical tretinoin preparations remained in their original form. In contrast, after 2 hours of exposure to fluorescent light only 25% of topical tretinoin and possibly 60% of topical isotretinoin remained in their original forms. Longer exposure to fluorescent light did not result in further breakdown, and the final breakdown of both preparations was similar. A 12-week, double-blind clinical trial comparing isotretinoin (0.05%) with tretinoin (0.05%) applied topically to patients with moderate acne was carried out. Both preparations caused significant reductions in papules and pustules. However, neither treatment was significantly superior to the other in the reduction of acne lesions. This may be because both preparations are rapidly broken down to similar products when exposed to fluorescent light.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2971693     DOI: 10.1016/s0190-9622(88)70202-9

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  3 in total

1.  Polymeric micelles of PEG-PE as carriers of all-trans retinoic acid for stability improvement.

Authors:  Angkana Wichit; Anothai Tangsumranjit; Tasana Pitaksuteepong; Neti Waranuch
Journal:  AAPS PharmSciTech       Date:  2012-01-25       Impact factor: 3.246

2.  Drug-cyclodextrin-vesicles dual carrier approach for skin targeting of anti-acne agent.

Authors:  Navjot Kaur; Richa Puri; Subheet Kumar Jain
Journal:  AAPS PharmSciTech       Date:  2010-03-24       Impact factor: 3.246

3.  Topical treatment of ichthyoses and Darier's disease with 13-cis-retinoic acid. A clinical and immunohistochemical study.

Authors:  P M Steijlen; D O Reifenschweiler; F C Ramaekers; G N van Muijen; R Happle; M Link; D J Ruiter; P C van de Kerkhof
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.